Led · Seed · Jan 2022

Syntegra generates synthetic healthcare data and statistical patterns of structured healthcare records. Its core product includes the Syntegra Medical Mind, a pre-trained model that has been trained on over 10 million records. The company creates built-for-purpose synthetic datasets to serve health systems, payers, life science and digital health companies, and clinical research organizations. Management says the technology is intended to advance data-driven innovation across customers. Syntegra is led by founder and CEO Michael D. Lesh. The company plans to commercialize new and ongoing work with health systems, payers, life science and digital health companies.

Participated · Series A · Dec 2021

Bureau is a San Francisco-based provider of a platform for businesses to verify customer identities and prevent fraud during online transactions. Its platform removes risk and blocks fraud concurrently by spotting abuse, monitoring transactions and enabling seamless identity verification. Led by founder and CEO Ranjan Reddy, the system has verified more than 600 million identities on behalf of over 150 customers. The company raised $30M in a Series B round led by Sorenson Capital, with participation from PayPal Ventures, Commerce Ventures, GMO Venture Partners and Village Global. Bureau intends to use the funds to expand operations and accelerate product development. Bureau builds an identity verification platform that maps digital persons and physical identities, tokenizing them behind mobile numbers to help companies prevent fraud and meet compliance. Its technology combines document verification, OCR, facematch, biometric checks, government database and AML checks, device and IP signals, and link analysis to assess identity risk. The platform is used across banking, fintech, insurance, the gig economy and real‑money gaming to detect mule accounts, synthetic IDs, account takeover, and to expand lending to new‑to‑credit customers. Bureau says it verified 300 million identities through its platform and grew customer and revenue numbers 6x over the past 12 months. It will use the new funding to invest in data and AI capabilities to automate decisioning and to expand coverage from 20 to more than 100 markets. Bureau positions itself as not being a data broker, sharing decisions rather than consumer data as part of its tokenized privacy architecture. Bureau offers a frictionless identity verification and fraud protection platform delivered via a single API to automate onboarding decisions and process insured users and transactions. The product focuses on end-to-end customer onboarding and fraud prevention for mobile-first enterprises. Bureau is ISO 27001:2013 certified and counts customers across fintech and financial services, including Jupiter Money, Goibibo, Aditya Birla Capital, ICICI Prudential, India Gold, and PhonePe. The company plans to use new funding to enhance its products and expand its footprint in India and South‑East Asia. It also intends to double down on capabilities such as account takeover prevention, transaction monitoring, and solutions for return-to-origin (RTO) and chargebacks use cases. Bureau was founded in 2020 by Reddy.

Participated · Seed · May 2021

The Public Health Company commercialized a modeling approach into subscription software that combines genomic variant analysis, epidemiologic investigations and conventional public-health data to help organizations detect, contain and manage disease outbreaks. Its platform automates analytic tools so decision-makers do not need in-house mathematicians, data scientists or infectious-disease doctors to interpret results. The company targets both government partners and private-sector enterprises with global operations—risk and continuity teams for warehouses, factories, insurers and hedge funds are cited as potential customers. Founder Charity Dean developed the underlying model during her public-health work and participated in state-level pandemic modeling efforts. The startup was formed last August and has grown to about 20 employees. Financially, it has secured $8 million in seed funding from institutional investors. The team positions disease risk management as a core continuity and insurance consideration analogous to cybersecurity.

Led · Series A · Apr 2021

Bespoke Financial provides technology-driven short-term lending and revolving lines of credit to licensed cannabis operators, using a data-driven application process and automated pre-qualification for dispensary financing. The company offers working capital to reduce cash flow cycles and enable business growth across the legal cannabis supply chain. Since its 2018 launch, Bespoke has funded businesses in 12 regulated markets and has financed lines of credit as large as $15 million. Bespoke’s platform is designed to bridge institutional investors and cannabis operators by mainstreaming cannabis debt financing. The company intends to expand lending capacity and serve as a conduit for larger pools of institutional capital ahead of any federal regulatory change. Bespoke is backed by venture firms including Casa Verde Capital, Sweat Equity Ventures, Greenhouse Capital Partners, Outbound Ventures, Ceres Group Holdings and Vista Investment Group. Bespoke Financial is a direct lender that provides short-term loans to cannabis operators, allowing borrowers to build credit with Bespoke and access better terms on subsequent loans and products. The company says its loan origination volume grew 25% year-over-year and has deployed $120 million in gross merchandise volume to over 2,000 cannabis license holders with zero defaults to date. Bespoke positions itself as a modern financing partner for the cannabis industry rather than just a lender. With the new capital, the company intends to launch new financing structures and expand financing options across multiple distribution channels. Bespoke has raised $28 million to date, was founded in 2019, and has 12 employees. Bespoke Financial provides lending and working-capital products tailored to cannabis businesses that lack access to traditional bank loans. The company’s initial product is a factoring instrument that advances money against signed contracts in exchange for a portion of future payments. Founders George Mancheril (ex-Goldman Sachs and Guggenheim) and entrepreneurs Pablo Borquez‑Schwarzbeck, Benjamin Dusastre, and Jeffrey Ghitman adapted ProducePay’s underwriting model to the cannabis supply chain. ProducePay previously financed roughly $2 billion in perishable commodities across 13 countries and is backed by around $200 million in venture capital and debt financing. Bespoke says it will improve cash flow cycles across the supply chain and provide scalable working capital to fuel client growth as the US legal cannabis market is forecast to exceed $23B by 2022. The company has raised $7 million in financing led by Casa Verde Capital.

Participated · Seed · Mar 2021

Sardine, headquartered in San Francisco, offers an agentic risk platform that unifies data across risk teams to stop fraud in real time, prevent AI-driven attacks, and automate fraud and AML operations. Its platform leverages device intelligence and real-time risk scoring and is used by customers across retail, commercial, and wealth lines. Sardine’s fraud consortium profiles over 6 billion devices, 800 million consumers, and 3 million businesses worldwide. The company counts customers such as FIS, GoDaddy, Intuit, Edward Jones, ZoomInfo, and Checkout.com and is expanding its footprint in financial services. Recent commercial momentum includes a multi-year partnership with National Bank of Canada, which followed a live evaluation demonstrating improved fraud detection and reduced false positives.